Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus Erythematosus

NCT04781816 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

Cutaneous Lupus Erythematosus

Interventions

DRUG: SAR443122
DRUG: Placebo

Sponsor

Sanofi